Monitoring Agency Report for the quarter ended September 30, 2026

October 16, 2026 National Stock Exchange of India Limited BSE Limited The Listing Department, Department of Corporate Services, Exchange Plaza, Phiroze Jeejeebhoy Towers, Bandra Kurla Complex, Dalal Street, Fort, Mumbai - 400 051 Mumbai - 400 001 Symbol: URBANCO Scrip Code: 544515 Sub.: Disclosure under Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Monitoring Agency Report for the quarter ended September 30, 2026 Dear Sir/ Ma’am, Pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Regulation 41 and other applicable provisions of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended, please find enclosed the Monitoring Agency Report dated October 16, 2026, issued by CARE Ratings Limited, Monitoring Agency, in respect of utilization of proceeds of the Initial Public Offer of the Company, for the quarter ended September 30, 2026, as reviewed and approved by the Audit Committee and the Board of Directors of the Company at their respective meetings held today, Friday, October 16, 2026. The aforesaid details will also be hosted on the Company's website viz. https://investorrelations.urbancompany.com/ This is for your information and record. Thanking you, For Urban Company Limited (Formerly UrbanClap Technologies India Limited and UrbanClap Technologies India Private Limited) Sonali Singh Company Secretary and Compliance Officer Membership No.: A26585 Encl.: As above Urban Company Limited Formerly known as UrbanClap Technologies India Limited & UrbanClap Technologies India Private Limited) REGISTERED OFFICE CORPORATE OFFICE Unit No. 8, Ground Floor, 7th & 8th Floor, Go Works, Rectangle 1, D4, Saket District Centre, Plot 183, Rajiv Nagar, Udyog Vihar New Delhi, 110017, Delhi, India Phase 1, Sector 20, Gurgaon - 122016, Haryana, India CIN L74140DL2014PLC274413 | Email: Peoplesuccess@urbancompany.com| www.urbancompany.com | Telephone: 91 11 444 570 56 No. CARE/NRO/GEN/2026-27/1128 The Board of Directors Urban Company Limited 7thand 8thFloor, Plot No 183 Udyog Vihar, Sector 20 Rajiv Nagar October 16, 2026 Monitoring Agency Report for the quarter ended September30, 2026 -in relation to the IPO of Urban Company We write in our capacity of Monitoring Agency for the Public Offer for the amount aggregating to Rs. 472.00 crore of the Company and refer to our duties cast under 41 of the Securities & Exchange Board of India (Issue of Capital & Disclosure Requirements) Regulations. In this connection, we are enclosing the Monitoring Agency Report for the quarter ended September30, 2026, as per aforesaid SEBI Regulations and Monitoring Agency Agreement dated September 02, 2025. Request you to kindly take the same on records. Thanking you, Yours faithfully, Rajan Sukhija Associate Director Rajan.sukhija@careedge.in CARE Ratings Limited 9th floor, C-001/A2, Berger Towers, Sector 16B, 4th Floor, Godrej Coliseum, Somaiya Hospital Noida, Road, Off Eastern Express Highway, Sion (East), Gautam Budh Nagar, Uttar Pradesh -201301 Mumbai -400 022 Phone: +91-120-4452000 Phone: +91-22-6754 3456 CIN-L67190MH1993PLC0716 Report of the Monitoring Agency Name of the issuer: Urban Company Limited For quarter ended: September30, 2026 Name of the Monitoring Agency: CARE Ratings Limited (a) Deviation from the objects: Nil (b) Range of Deviation:Not Applicable Declaration: We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the objects of the issue based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable. The MA does not perform an audit and undertakes no independent verification of any information/ certifications/ statements it receives. This Report is not intended to create any legally binding obligations on the MA which accepts no responsibility, whatsoever, for loss or damage from the use of the said information. The views and opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner whatsoever. Nothing mentioned in this report is intendedto or should be construed as creating a fiduciary relationship between the MA and any issuer or between the agency and any user of this report. The MA and its affiliates also do not act as an expert as defined under Section 2(38) of the Companies Act, 2013. The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report pertains and may receive separate compensation for its ratings and certain credit-related analyses. We confirm that there is no conflict ofinterest in such relationship/interest while monitoring and reporting the utilization of the issue proceeds by the issuer, or while undertaking credit rating or other commercial transactions with the entity. We have submitted the report herewith in line with the format prescribed by SEBI, capturing our comments where Management / Audit Committee of the Board of Directors subsequent to the MA submitting their report to the issuer and before dissemination of the report through stock exchanges. These sections have not been reviewed by the MA, and the MA takes no responsi Signature: Name and designation of the Authorized Signatory: Rajan Sukhija Designation of Authorized person/Signing Authority: Associate Director CARE Ratings Limited 9th floor, C-001/A2, Berger Towers, Sector 16B, 4th Floor, Godrej Coliseum, Somaiya Hospital Noida, Road, Off Eastern Express Highway, Sion (East), Gautam Budh Nagar, Uttar Pradesh -201301 Mumbai -400 022 Phone: +91-120-4452000 Phone: +91-22-6754 3456 CIN-L67190MH1993PLC0716 Disclaimers to MA report: a) This Report is prepared by CARE Ratings Ltd (hereinafter referred to as ). The MA has taken utmost care to ensure accuracy and objectivity while developing this Report based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable. The views and opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner whatsoever. b) This Report has to be seen in its entirety; the selective review of portions of the Report may lead to inaccurate assessments. For the purpose of this Report, MA has relied upon the information provided by the management /officials/ consultants of the Issuer and third-party sources like statutory auditor/internal auditor which is peer reviewed audit firm/peer reviewed audit firm appointed by the Issuer believed by it to be accurate and reliable. c) Nothing contained in this Report is capable or intended to create any legally binding obligations on the MA which accepts no responsibility, whatsoever, for loss or damage from the use of the said information. The MA is also not responsible for any errors in transmission and specifically states that it, or its directors, employees do not have any financial liabilities whatsoever to the users of this Report. d) The MA and its affiliates do not act as a fiduciary. The MA and its affiliates also do not act as an expert to the extent defined under Section 2(38) of the Companies Act, 2013. While the MA has obtained information from sources it believes to be reliable, it does not perform an audit and undertakes no independent verification of any information/ certifications/ statements it receives from statutory auditors/internal auditor which is peer reviewed audit firm/peer reviewed audit firm (or from peer reviewed CA firms), lawyers, chartered engineers or other experts, and relies on in its reports. e) The MA or its affiliates may have other commercial transactions with the entity to which the report pertains. As an example, the MA may rate the issuer or any debt instruments / facilities issued or proposed to be issued by the issuer that is subject matter of this report. The MA may receive separate compensation f [Showing first 8,000 characters — download PDF for full document]